INVESTOR RELATIONS

Please contact us for any investment or investor  related inquiries.  

​

Your investment in Stramsen Biotech Inc. will be a catalyst for transformative growth and value creation. As we advance towards submitting Investigational New Drug (IND) Applications to the FDA and initiate groundbreaking clinical trials, your support will enable us to expand our talented team and accelerate our mission.

​

These pivotal developments are poised to significantly enhance our company's value, potentially leading to substantial increases in future enterprise valuations. As a result, shareholders can anticipate a likely increase in share price in the near future, offering an exciting opportunity for growth and returns.

​

By partnering with Stramsen Biotech Inc., you're not just investing in a company; you're investing in the future of plant-based medicine and the potential to transform countless lives. Join us in this revolutionary journey towards redefining pharmaceutical innovation and creating lasting value for patients and investors alike.

​

At Stramsen Biotech Inc., we are committed to protecting and maximizing value for our current shareholders and future investors. This commitment has led us to make strategic decisions that prioritize long-term growth and stability over short-term gains. We have carefully evaluated and ultimately declined merger offers from shell companies, as well as OTC and penny stock companies, recognizing that such moves could potentially dilute shareholder value and introduce unnecessary volatility to our stock price.

​

Our decision to remain independent demonstrates our confidence in Stramsen Biotech's innovative approach to plant-based drug development and our strong market position. By maintaining our focus and integrity, we are better positioned to deliver on our promise of transforming patients' lives through our pipeline of 33 plant-based drug candidates. This steadfast approach not only safeguards the interests of our current stakeholders but also creates a solid foundation for attracting serious, long-term investors who share our vision for revolutionary biopharmaceutical advancements.

​

We believe that this strategic stance will ultimately yield greater returns and stability for all our shareholders. By avoiding the uncertainties associated with mergers involving less stable entities, we are paving the way for sustainable growth and ensuring that Stramsen Biotech remains at the forefront of plant-based medicine development. Our commitment to you, our valued shareholders and future investors, remains unwavering as we continue to push the boundaries of biopharmaceutical innovation.

 

Interested Private investors are encouraged to call or email Stramsen Biotech, Inc for more information about company's team of scientists and information about ongoing medicine research projects. Funding is for company’s next phases of clinical trials, additional medicine discoveries and research projects.